PhDEdBarkerEd Barker41.87386750000000-87.67102690000000349564Barker, EdMy Scopus ID is 7103411264.
My NIH COMMONS name is BARKERE.
Research Areas:
Natural killer cells and HIV, innate lymphoid cells in HIV infection.
My Faculty Profile at Rush University Medical Center:
https://www.rushu.rush.edu/faculty/edward-barker-phd
My Laboratory:
https://www.rushu.rush.edu/research/departmental-research/microbial-pathogens-and-immunity-research/laboratory-edward-barker-phd
My NCBI Bibliography:
https://www.ncbi.nlm.nih.gov/myncbi/browse/collection/46831905/?sort=date&direction=descending
My Scopus:
https://www.scopus.com/authid/detail.uri?authorId=7103411264
Education:
PhD, University of Illinois312-942-3136Professorprns:coAuthorOfcoauthor ofFaculty Rankprns:fullNamefull nameprns:hasAuthorListauthor listprns:hasFacultyRankhas faculty rankprns:hasNetworkhas networkprns:hasPublicationVenuepublished inprns:informationResourceReferenceinformation resource referenceprns:isPrimaryPositionis primary positionprns:latitudelatitudeprns:longitudelongitudeprns:mainImagephotoprns:maxWeightmaximum weightprns:medlineTAjournal title abbreviationprns:meshDescriptorUIMeSH DescriptorUIprns:meshSemanticGroupNameMeSH semantic group nameprns:minWeightminimum weightprns:numberOfAuthorsnumber of authorsprns:numberOfConnectionsnumber of connectionsprns:numberOfPublicationsnumber of publicationsprns:personIdPerson IDprns:personInPrimaryPositionperson in primary positionprns:physicalNeighborOfphysical neighborprns:positionInDepartmentposition in departmentprns:positionInDivisionposition in divisionprns:predicateNodepredicate nodeprns:publicationDatepublication dateprns:similarTosimilar toprns:sortOrdersort orderprns:uniquenessWeightuniqueness weightprns:yearyearAcademic ArticleArticleDocumentbibo:pmidPubMed Identifierbibo:suffixNamename suffixAddressvivo:address1address line 1vivo:addressCitycityvivo:addressPostalCodepostal codevivo:addressStatestate or provincevivo:authorInAuthorshipselected publicationsvivo:authorRankauthor rank in publicationAuthorshipDepartmentDivisionvivo:hasResearchArearesearch areasvivo:hrJobTitleHR job titleInformation Resourcevivo:linkedAuthorlinked authorvivo:linkedInformationResourcelinked information resourcevivo:mailingAddressmailing addressvivo:orcidIdORCID idvivo:overviewoverviewvivo:personInPositionpositionsvivo:phoneNumberphonePositionvivo:positionInOrganizationposition in organizationvivo:preferredTitlepreferred titlerdf:predicatepredicaterdf:typetyperdfs:labellabelConceptAgentfoaf:firstNamefirst namefoaf:lastNamelast nameOrganizationPersonD015497Living Beings404380.762934HIV-1Authorship 340901Authorship 34218377479952Barker E, Mackewicz CE, Levy JAProceedings of the National Academy of Sciences of the United States of AmericaEffects of TH1 and TH2 cytokines on CD8+ cell response against human immunodeficiency virus: implications for long-term survival. Proc Natl Acad Sci U S A. 1995 Nov 21; 92(24):11135-9.Proc Natl Acad Sci U S A1995-11-21T00:00:001995Effects of TH1 and TH2 cytokines on CD8+ cell response against human immunodeficiency virus: implications for long-term survival.30525907Tay N, Macare C, Liu Y, Ruggeri B, Jia T, Chu C, Biondo F, Ing A, Luo Q, Sarkysian D, Banaschewski T, Barker GJ, Bokde ALW, Bromberg U, B?chel C, Quinlan EB, Desrivi?res S, Flor H, Frouin V, Garavan H, Gowland P, Heinz A, Ittermann B, Martinot JL, Artiges E, Nees F, Orfanos DP, Paus T, Poustka L, Hohmann S, Fr?hner JH, Smolka MN, Walter H, Whelan R, Frieling H, Bleich S, Barker ED, Syv?nen AC, R?egg J, Ekstr?m TJ, Bakalkin G, Schumann GThe American journal of psychiatryAllele-Specific Methylation of SPDEF: A Novel Moderator of Psychosocial Stress and Substance Abuse. Am J Psychiatry. 2019 02 01; 176(2):146-155.Am J Psychiatry2018-12-11T00:00:002018Allele-Specific Methylation of SPDEF: A Novel Moderator of Psychosocial Stress and Substance Abuse.Authorship 34946410852784Hamada H, Vallyathan V, Cool CD, Barker E, Inoue Y, Newman LSAmerican journal of respiratory and critical care medicineMast cell basic fibroblast growth factor in silicosis. Am J Respir Crit Care Med. 2000 Jun; 161(6):2026-34.Am J Respir Crit Care Med2000-06-01T00:00:002000Mast cell basic fibroblast growth factor in silicosis.Authorship 35082830984202Castleman MJ, Dillon SM, Purba CM, Cogswell AC, Kibbie JJ, McCarter MD, Santiago ML, Barker E, Wilson CCFrontiers in immunologyCommensal and Pathogenic Bacteria Indirectly Induce IL-22 but Not IFN? Production From Human Colonic ILC3s via Multiple Mechanisms. Front Immunol. 2019; 10:649.Front Immunol2019-03-29T00:00:002019Commensal and Pathogenic Bacteria Indirectly Induce IL-22 but Not IFN? Production From Human Colonic ILC3s via Multiple Mechanisms.true1Associate ProfessorAssociate Professor18090295Barker E, Martinson J, Brooks C, Landay A, Deeks SAIDS (London, England)Dysfunctional natural killer cells, in vivo, are governed by HIV viremia regardless of whether the infected individual is on antiretroviral therapy. AIDS. 2007 Nov 12; 21(17):2363-5.AIDS2007-11-12T00:00:002007Dysfunctional natural killer cells, in vivo, are governed by HIV viremia regardless of whether the infected individual is on antiretroviral therapy.8148441Barker E, Fujimura SF, Fadem MB, Landay AL, Levy JAClinical infectious diseases : an official publication of the Infectious Diseases Society of AmericaImmunologic abnormalities associated with chronic fatigue syndrome. Clin Infect Dis. 1994 Jan; 18 Suppl 1:S136-41.Clin Infect Dis1994-01-01T00:00:001994Immunologic abnormalities associated with chronic fatigue syndrome.22291932Manion M, Rodriguez B, Medvik K, Hardy G, Harding CV, Schooley RT, Pollard R, Asmuth D, Murphy R, Barker E, Brady KE, Landay A, Funderburg N, Sieg SF, Lederman MMPloS oneInterferon-alpha administration enhances CD8+ T cell activation in HIV infection. PLoS One. 2012; 7(1):e30306.PLoS One2012-01-24T00:00:002012Interferon-alpha administration enhances CD8+ T cell activation in HIV infection.Authorship 37080631583949Castleman MJ, Dillon SM, Purba C, Cogswell AC, McCarter M, Barker E, Wilson CGut microbesEnteric bacteria induce IFN? and Granzyme B from human colonic Group 1 Innate Lymphoid Cells. Gut Microbes. 2020 11 09; 12(1):1667723.Gut Microbes2019-10-04T00:00:002019Enteric bacteria induce IFN? and Granzyme B from human colonic Group 1 Innate Lymphoid Cells.PediatricsPsychiatryCelesteNapierCeleste Napier41.87386750000000-87.67102690000000349114Napier, CelesteProfessor1735 W. Harrison St.Chicago60612ILLenaAl-HarthiLena Al-Harthi41.87386750000000-87.67102690000000349563Al-Harthi, Lena0000-0003-3915-3904Professor1153selected publications5.895620.00532728280research areas0.1782960.1782961coauthor of231.3224.5579360similar toSeemaDesaiSeema N. Desai41.87386750000000-87.67102690000000349566Desai, SeemaAssistant ProfessorSashaShafikhaniSasha H. Shafikhani41.87386750000000-87.67102690000000349571Shafikhani, SashaAssociate ProfessorKathleenWeberKathleen Weber349609Weber, KathleenAssistant Professor6Assistant Professor5Associate Professor4ProfessorAuthorship 38528332051277Cogswell A, Ferguson N, Barker EJournal of virologyPresence of Inflammatory Group I and III Innate Lymphoid Cells in the Colon of Simian Immunodeficiency Virus-Infected Rhesus Macaques. J Virol. 2020 04 16; 94(9).J Virol2020-04-16T00:00:002020Presence of Inflammatory Group I and III Innate Lymphoid Cells in the Colon of Simian Immunodeficiency Virus-Infected Rhesus Macaques.D016097Disorders4220.973284Simian Acquired Immunodeficiency SyndromeAuthorship 3910219787145Barker E, Mackewicz CE, Reyes-Ter?n G, Sato A, Stranford SA, Fujimura SH, Christopherson C, Chang SY, Levy JABloodVirological and immunological features of long-term human immunodeficiency virus-infected individuals who have remained asymptomatic compared with those who have progressed to acquired immunodeficiency syndrome. Blood. 1998 Nov 01; 92(9):3105-14.Blood1998-11-01T00:00:001998Virological and immunological features of long-term human immunodeficiency virus-infected individuals who have remained asymptomatic compared with those who have progressed to acquired immunodeficiency syndrome.D007694Anatomy26900.945053Killer Cells, NaturalD015658Disorders849700.579945HIV InfectionsAuthorship 106014Authorship 107217Authorship 112552Authorship 121569Authorship 123221Authorship 126612Authorship 131782Authorship 137894Authorship 140682Authorship 142123Authorship 146802Authorship 1483911Authorship 156301Authorship 162009Authorship 164741Authorship 165144Authorship 1671910Authorship 1709910Authorship 172984Authorship 176893Authorship 176913Authorship 178556Authorship 184355Authorship 18958715117765Bonaparte MI, Barker EBloodKilling of human immunodeficiency virus-infected primary T-cell blasts by autologous natural killer cells is dependent on the ability of the virus to alter the expression of major histocompatibility complex class I molecules. Blood. 2004 Oct 01; 104(7):2087-94.Blood2004-04-29T00:00:002004Killing of human immunodeficiency virus-infected primary T-cell blasts by autologous natural killer cells is dependent on the ability of the virus to alter the expression of major histocompatibility complex class I molecules.15316337Ward JP, Bonaparte MI, Barker EAIDS (London, England)HLA-C and HLA-E reduce antibody-dependent natural killer cell-mediated cytotoxicity of HIV-infected primary T cell blasts. AIDS. 2004 Sep 03; 18(13):1769-79.AIDS2004-09-03T00:00:002004HLA-C and HLA-E reduce antibody-dependent natural killer cell-mediated cytotoxicity of HIV-infected primary T cell blasts.16862069Pang J, Cheng M, Haire SE, Barker E, Planelles V, Blanks JCMolecular visionEfficiency of lentiviral transduction during development in normal and rd mice. Mol Vis. 2006 Jul 11; 12:756-67.Mol Vis2006-07-11T00:00:002006Efficiency of lentiviral transduction during development in normal and rd mice.17513617Ward J, Bonaparte M, Sacks J, Guterman J, Fogli M, Mavilio D, Barker EBloodHIV modulates the expression of ligands important in triggering natural killer cell cytotoxic responses on infected primary T-cell blasts. Blood. 2007 Aug 15; 110(4):1207-14.Blood2007-05-18T00:00:002007HIV modulates the expression of ligands important in triggering natural killer cell cytotoxic responses on infected primary T-cell blasts.17609265Banerjee P, Feuer G, Barker EJournal of virologyHuman T-cell leukemia virus type 1 (HTLV-1) p12I down-modulates ICAM-1 and -2 and reduces adherence of natural killer cells, thereby protecting HTLV-1-infected primary CD4+ T cells from autologous natural killer cell-mediated cytotoxicity despite the reduction of major histocompatibility complex class I molecules on infected cells. J Virol. 2007 Sep; 81(18):9707-17.J Virol2007-07-03T00:00:002007Human T-cell leukemia virus type 1 (HTLV-1) p12I down-modulates ICAM-1 and -2 and reduces adherence of natural killer cells, thereby protecting HTLV-1-infected primary CD4+ T cells from autologous natural killer cell-mediated cytotoxicity despite the reduction of major histocompatibility complex class I molecules on infected cells.18417035Ward J, Barker ECurrent HIV/AIDS reportsRole of natural killer cells in HIV pathogenesis. Curr HIV/AIDS Rep. 2008 Feb; 5(1):44-50.Curr HIV/AIDS Rep2008-02-01T00:00:002008Role of natural killer cells in HIV pathogenesis.18617991Fogli M, Mavilio D, Brunetta E, Varchetta S, Ata K, Roby G, Kovacs C, Follmann D, Pende D, Ward J, Barker E, Marcenaro E, Moretta A, Fauci ASPLoS pathogensLysis of endogenously infected CD4+ T cell blasts by rIL-2 activated autologous natural killer cells from HIV-infected viremic individuals. PLoS Pathog. 2008 Jul 11; 4(7):e1000101.PLoS Pathog2008-07-11T00:00:002008Lysis of endogenously infected CD4+ T cell blasts by rIL-2 activated autologous natural killer cells from HIV-infected viremic individuals.19798433Ward J, Davis Z, DeHart J, Zimmerman E, Bosque A, Brunetta E, Mavilio D, Planelles V, Barker EPLoS pathogensHIV-1 Vpr triggers natural killer cell-mediated lysis of infected cells through activation of the ATR-mediated DNA damage response. PLoS Pathog. 2009 Oct; 5(10):e1000613.PLoS Pathog2009-10-02T00:00:002009HIV-1 Vpr triggers natural killer cell-mediated lysis of infected cells through activation of the ATR-mediated DNA damage response.20558198Planelles V, Barker EMolecular aspects of medicineRoles of Vpr and Vpx in modulating the virus-host cell relationship. Mol Aspects Med. 2010 Oct; 31(5):398-406.Mol Aspects Med2010-06-15T00:00:002010Roles of Vpr and Vpx in modulating the virus-host cell relationship.21075351Shah AH, Sowrirajan B, Davis ZB, Ward JP, Campbell EM, Planelles V, Barker ECell host & microbeDegranulation of natural killer cells following interaction with HIV-1-infected cells is hindered by downmodulation of NTB-A by Vpu. Cell Host Microbe. 2010 Nov 18; 8(5):397-409.Cell Host Microbe2010-11-18T00:00:002010Degranulation of natural killer cells following interaction with HIV-1-infected cells is hindered by downmodulation of NTB-A by Vpu.21445040Davis ZB, Ward JP, Barker EJournal of visualized experiments : JoVEPreparation and use of HIV-1 infected primary CD4+ T-cells as target cells in natural killer cell cytotoxic assays. J Vis Exp. 2011 Mar 14; (49).J Vis Exp2011-03-14T00:00:002011Preparation and use of HIV-1 infected primary CD4+ T-cells as target cells in natural killer cell cytotoxic assays.21994772Sowrirajan B, Barker EVirusesThe natural killer cell cytotoxic function is modulated by HIV-1 accessory proteins. Viruses. 2011 07; 3(7):1091-111.Viruses2011-07-08T00:00:002011The natural killer cell cytotoxic function is modulated by HIV-1 accessory proteins.23308067Sauter D, Unterweger D, Vogl M, Usmani SM, Heigele A, Kluge SF, Hermkes E, Moll M, Barker E, Peeters M, Learn GH, Bibollet-Ruche F, Fritz JV, Fackler OT, Hahn BH, Kirchhoff FPLoS pathogensHuman tetherin exerts strong selection pressure on the HIV-1 group N Vpu protein. PLoS Pathog. 2012 Dec; 8(12):e1003093.PLoS Pathog2012-12-20T00:00:002012Human tetherin exerts strong selection pressure on the HIV-1 group N Vpu protein.24091697Dillon SM, Lee EJ, Bramante JM, Barker E, Wilson CCJournal of acquired immune deficiency syndromes (1999)The natural killer cell interferon-gamma response to bacteria is diminished in untreated HIV-1 infection and defects persist despite viral suppression. J Acquir Immune Defic Syndr. 2014 Mar 01; 65(3):259-67.J Acquir Immune Defic Syndr2014-03-01T00:00:002014The natural killer cell interferon-gamma response to bacteria is diminished in untreated HIV-1 infection and defects persist despite viral suppression.24910430Ramirez PW, Famiglietti M, Sowrirajan B, DePaula-Silva AB, Rodesch C, Barker E, Bosque A, Planelles VCell reportsDownmodulation of CCR7 by HIV-1 Vpu results in impaired migration and chemotactic signaling within CD4? T cells. Cell Rep. 2014 Jun 26; 7(6):2019-30.Cell Rep2014-06-05T00:00:002014Downmodulation of CCR7 by HIV-1 Vpu results in impaired migration and chemotactic signaling within CD4? T cells.25499532Cassiday PA, DePaula-Silva AB, Chumley J, Ward J, Barker E, Planelles VVirologyUnderstanding the molecular manipulation of DCAF1 by the lentiviral accessory proteins Vpr and Vpx. Virology. 2015 Feb; 476:19-25.Virology2014-12-11T00:00:002014Understanding the molecular manipulation of DCAF1 by the lentiviral accessory proteins Vpr and Vpx.26215564Ramirez PW, DePaula-Silva AB, Szaniawski M, Barker E, Bosque A, Planelles VRetrovirologyHIV-1 Vpu utilizes both cullin-RING ligase (CRL) dependent and independent mechanisms to downmodulate host proteins. Retrovirology. 2015 Jul 28; 12:65.Retrovirology2015-07-28T00:00:002015HIV-1 Vpu utilizes both cullin-RING ligase (CRL) dependent and independent mechanisms to downmodulate host proteins.26828202Davis ZB, Cogswell A, Scott H, Mertsching A, Boucau J, Wambua D, Le Gall S, Planelles V, Campbell KS, Barker EPLoS pathogensA Conserved HIV-1-Derived Peptide Presented by HLA-E Renders Infected T-cells Highly Susceptible to Attack by NKG2A/CD94-Bearing Natural Killer Cells. PLoS Pathog. 2016 Feb; 12(2):e1005421.PLoS Pathog2016-02-01T00:00:002016A Conserved HIV-1-Derived Peptide Presented by HLA-E Renders Infected T-cells Highly Susceptible to Attack by NKG2A/CD94-Bearing Natural Killer Cells.26962229Boudreau JE, Mulrooney TJ, Le Luduec JB, Barker E, Hsu KCJournal of immunology (Baltimore, Md. : 1950)KIR3DL1 and HLA-B Density and Binding Calibrate NK Education and Response to HIV. J Immunol. 2016 Apr 15; 196(8):3398-410.J Immunol2016-03-09T00:00:002016KIR3DL1 and HLA-B Density and Binding Calibrate NK Education and Response to HIV.27173922Barker E, Evans DTCell host & microbeHLA-C Downmodulation by HIV-1 Vpu. Cell Host Microbe. 2016 05 11; 19(5):570-1.Cell Host Microbe2016-05-11T00:00:002016HLA-C Downmodulation by HIV-1 Vpu.12598768Bonaparte MI, Barker EAIDS (London, England)Inability of natural killer cells to destroy autologous HIV-infected T lymphocytes. AIDS. 2003 Mar 07; 17(4):487-94.AIDS2003-03-07T00:00:002003Inability of natural killer cells to destroy autologous HIV-infected T lymphocytes.12700118Barker E, Planelles VFrontiers in bioscience : a journal and virtual libraryVectors derived from the human immunodeficiency virus, HIV-1. Front Biosci. 2003 May 01; 8:d491-510.Front Biosci2003-05-01T00:00:002003Vectors derived from the human immunodeficiency virus, HIV-1.D015302Living Beings5220.973553Simian Immunodeficiency VirusInternal MedicineNeurological SciencesRush University, Rush Medical CollegeAlanLandayAlan L. Landay41.87386750000000-87.67102690000000349009Landay, AlanProfessorAliKeshavarzianAli Keshavarzian41.87386750000000-87.67102690000000349021Keshavarzian, AliProfessorAuthorship 41900634117105Castleman MJ, Dillon SM, Thompson TA, Santiago ML, McCarter MD, Barker E, Wilson CCJournal of immunology (Baltimore, Md. : 1950)Gut Bacteria Induce Granzyme B Expression in Human Colonic ILC3s In Vitro in an IL-15-Dependent Manner. J Immunol. 2021 06 15; 206(12):3043-3052.J Immunol2021-06-11T00:00:002021Gut Bacteria Induce Granzyme B Expression in Human Colonic ILC3s In Vitro in an IL-15-Dependent Manner.Authorship 448723Authorship 45271535311549Cogswell A, Jo S, Ferguson N, Gupta K, Barker EJournal of virologyPresence of Natural Killer B Cells in Simian Immunodeficiency Virus-Infected Colon That Have Properties and Functions Similar to Those of Natural Killer Cells and B Cells but Are a Distinct Cell Population. J Virol. 2022 04 13; 96(7):e0023522.J Virol2022-03-21T00:00:002022Presence of Natural Killer B Cells in Simian Immunodeficiency Virus-Infected Colon That Have Properties and Functions Similar to Those of Natural Killer Cells and B Cells but Are a Distinct Cell Population.35459417Ferguson N, Cogswell A, Barker EAIDS research and human retrovirusesContribution of Innate Lymphoid Cells in Supplementing Cytokines Produced by CD4+ T Cells During Acute and Chronic SIV Infection of the Colon. AIDS Res Hum Retroviruses. 2022 09; 38(9):709-725.AIDS Res Hum Retroviruses2022-06-30T00:00:002022Contribution of Innate Lymphoid Cells in Supplementing Cytokines Produced by CD4+ T Cells During Acute and Chronic SIV Infection of the Colon.true1ProfessorProfessorInternal Medicine, Division of Digestive Diseases and NutritionIgorKoralnikIgor J. Koralnik349837Koralnik, IgorProfessortrue1ProfessorProfessorAuthorship 256146Authorship 25916527296670Davis ZB, Sowrirajan B, Cogswell A, Ward JP, Planelles V, Barker EAIDS research and human retrovirusesCD155 on HIV-Infected Cells Is Not Modulated by HIV-1 Vpu and Nef but Synergizes with NKG2D Ligands to Trigger NK Cell Lysis of Autologous Primary HIV-Infected Cells. AIDS Res Hum Retroviruses. 2017 02; 33(2):93-100.AIDS Res Hum Retroviruses2016-07-20T00:00:002016CD155 on HIV-Infected Cells Is Not Modulated by HIV-1 Vpu and Nef but Synergizes with NKG2D Ligands to Trigger NK Cell Lysis of Autologous Primary HIV-Infected Cells.27708642Garrido C, Spivak AM, Soriano-Sarabia N, Checkley MA, Barker E, Karn J, Planelles V, Margolis DMFrontiers in immunologyHIV Latency-Reversing Agents Have Diverse Effects on Natural Killer Cell Function. Front Immunol. 2016; 7:356.Front Immunol2016-09-21T00:00:002016HIV Latency-Reversing Agents Have Diverse Effects on Natural Killer Cell Function.true1Assistant ProfessorAssistant Professortrue1ProfessorProfessorInternal Medicine, Division of Geriatrics, Gerontology and Palliative MedicineInternal Medicine, Division of Hematology, Oncology and Cell TherapyAuthorship 2847933Authorship 28810828825942Dillon SM, Castleman MJ, Frank DN, Austin GL, Gianella S, Cogswell AC, Landay AL, Barker E, Wilson CCJournal of acquired immune deficiency syndromes (1999)Brief Report: Inflammatory Colonic Innate Lymphoid Cells Are Increased During Untreated HIV-1 Infection and Associated With Markers of Gut Dysbiosis and Mucosal Immune Activation. J Acquir Immune Defic Syndr. 2017 12 01; 76(4):431-437.J Acquir Immune Defic Syndr2017-12-01T00:00:002017Brief Report: Inflammatory Colonic Innate Lymphoid Cells Are Increased During Untreated HIV-1 Infection and Associated With Markers of Gut Dysbiosis and Mucosal Immune Activation.28618856Quinlan EB, Cattrell A, Jia T, Artiges E, Banaschewski T, Barker G, Bokde ALW, Bromberg U, B?chel C, Br?hl R, Conrod PJ, Desrivieres S, Flor H, Frouin V, Gallinat J, Garavan H, Gowland P, Heinz A, Martinot JL, Paill?re Martinot ML, Nees F, Papadopoulos-Orfanos D, Paus T, Poustka L, Smolka MN, Vetter NC, Walter H, Whelan R, Glennon JC, Buitelaar JK, Happ? F, Loth E, Barker ED, Schumann GThe American journal of psychiatryPsychosocial Stress and Brain Function in Adolescent Psychopathology. Am J Psychiatry. 2017 08 01; 174(8):785-794.Am J Psychiatry2017-06-16T00:00:002017Psychosocial Stress and Brain Function in Adolescent Psychopathology.true1ProfessorProfessorMicrobial Pathogens and ImmunityAuthorship 4646819834109Barker E, Bossart KN, Levy JAJournal of immunology (Baltimore, Md. : 1950)Differential effects of CD28 costimulation on HIV production by CD4+ cells. J Immunol. 1998 Dec 01; 161(11):6223-7.J Immunol1998-12-01T00:00:001998Differential effects of CD28 costimulation on HIV production by CD4+ cells.true1ProfessorProfessorAuthorship 316413Authorship 316421Authorship 316432Authorship 316442Authorship 316451Authorship 316461Authorship 316471Authorship 316481Authorship 316493Authorship 316501Authorship 316511Authorship 316522Authorship 316531Authorship 3165471901031Weiskirch LM, Baumgartel BA, Barker E, Mokyr MBCancer immunology, immunotherapy : CIIPhorbol ester-induced enhancement in lytic activity of CD8+ splenic T cells from low-dose melphalan-treated MOPC-315-tumor bearers. Cancer Immunol Immunother. 1991; 32(6):353-63.Cancer Immunol Immunother1991-01-01T00:00:001991Phorbol ester-induced enhancement in lytic activity of CD8+ splenic T cells from low-dose melphalan-treated MOPC-315-tumor bearers.1988079Barker E, Mueller BM, Handgretinger R, Herter M, Yu AL, Reisfeld RACancer researchEffect of a chimeric anti-ganglioside GD2 antibody on cell-mediated lysis of human neuroblastoma cells. Cancer Res. 1991 Jan 01; 51(1):144-9.Cancer Res1991-01-01T00:00:001991Effect of a chimeric anti-ganglioside GD2 antibody on cell-mediated lysis of human neuroblastoma cells.2337902Weiskirch LM, Barker E, Mokyr MBCancer immunology, immunotherapy : CIIEradication of a large MOPC-315 tumor in athymic nude mice by chemoimmunotherapy with Lyt2+ splenic T cells from melphalan-treated BALB/c mice bearing a large MOPC-315 tumor. Cancer Immunol Immunother. 1990; 31(3):129-38.Cancer Immunol Immunother1990-01-01T00:00:001990Eradication of a large MOPC-315 tumor in athymic nude mice by chemoimmunotherapy with Lyt2+ splenic T cells from melphalan-treated BALB/c mice bearing a large MOPC-315 tumor.2568174Mokyr MB, Barker E, Weiskirch LM, Takesue BY, Pyle JMCancer researchImportance of Lyt 2+ T-cells in the curative effectiveness of a low dose of melphalan for mice bearing a large MOPC-315 tumor. Cancer Res. 1989 Aug 15; 49(16):4597-606.Cancer Res1989-08-15T00:00:001989Importance of Lyt 2+ T-cells in the curative effectiveness of a low dose of melphalan for mice bearing a large MOPC-315 tumor.2788494Barker E, Wise JA, Dray S, Mokyr MBCancer researchLysis of antigenically unrelated tumor cells mediated by Lyt 2+ splenic T-cells from melphalan-cured MOPC-315 tumor bearers. Cancer Res. 1989 Sep 15; 49(18):5007-15.Cancer Res1989-09-15T00:00:001989Lysis of antigenically unrelated tumor cells mediated by Lyt 2+ splenic T-cells from melphalan-cured MOPC-315 tumor bearers.3261626Barker E, Mokyr MBCancer researchImportance of Lyt-2+ T-cells in the resistance of melphalan-cured MOPC-315 tumor bearers to a challenge with MOPC-315 tumor cells. Cancer Res. 1988 Sep 01; 48(17):4834-42.Cancer Res1988-09-01T00:00:001988Importance of Lyt-2+ T-cells in the resistance of melphalan-cured MOPC-315 tumor bearers to a challenge with MOPC-315 tumor cells.3677124Barker E, Mokyr MBCancer immunology, immunotherapy : CIISome characteristics of the in vivo antitumor immunity exhibited by mice cured of a large MOPC-315 tumor by a low dose of melphalan. Cancer Immunol Immunother. 1987; 25(3):215-24.Cancer Immunol Immunother1987-01-01T00:00:001987Some characteristics of the in vivo antitumor immunity exhibited by mice cured of a large MOPC-315 tumor by a low dose of melphalan.8571134Levy JA, Ramachandran B, Barker E, Guthrie J, Elbeik TScience (New York, N.Y.)Plasma viral load, CD4+ cell counts, and HIV-1 production by cells. Science. 1996 Feb 02; 271(5249):670-1.Science1996-02-02T00:00:001996Plasma viral load, CD4+ cell counts, and HIV-1 production by cells.9000085Barker E, Bossart KN, Locher CP, Patterson BK, Levy JAThe Journal of general virologyCD8+ cells from asymptomatic human immunodeficiency virus-infected individuals suppress superinfection of their peripheral blood mononuclear cells. J Gen Virol. 1996 Dec; 77 ( Pt 12):2953-62.J Gen Virol1996-12-01T00:00:001996CD8+ cells from asymptomatic human immunodeficiency virus-infected individuals suppress superinfection of their peripheral blood mononuclear cells.9465084Barker E, Bossart KN, Levy JAProceedings of the National Academy of Sciences of the United States of AmericaPrimary CD8+ cells from HIV-infected individuals can suppress productive infection of macrophages independent of beta-chemokines. Proc Natl Acad Sci U S A. 1998 Feb 17; 95(4):1725-9.Proc Natl Acad Sci U S A1998-02-17T00:00:001998Primary CD8+ cells from HIV-infected individuals can suppress productive infection of macrophages independent of beta-chemokines.9824318Greco G, Barker E, Levy JAAIDS research and human retrovirusesDifferences in HIV replication in CD4+ lymphocytes are not related to beta-chemokine production. AIDS Res Hum Retroviruses. 1998 Nov 01; 14(16):1407-11.AIDS Res Hum Retroviruses1998-11-01T00:00:001998Differences in HIV replication in CD4+ lymphocytes are not related to beta-chemokine production.10527561Barker E, Bossart KN, Fujimura SH, Levy JACellular immunologyThe role of CD80 and CD86 in enhancing CD8(+) cell suppression of HIV replication. Cell Immunol. 1999 Sep 15; 196(2):95-103.Cell Immunol1999-09-15T00:00:001999The role of CD80 and CD86 in enhancing CD8(+) cell suppression of HIV replication.11080825Wrzesinski S, S?guin R, Liu Y, Domville S, Planelles V, Massa P, Barker E, Antel J, Feuer GAIDS research and human retrovirusesHTLV type 1 Tax transduction in microglial cells and astrocytes by lentiviral vectors. AIDS Res Hum Retroviruses. 2000 Nov 01; 16(16):1771-6.AIDS Res Hum Retroviruses2000-11-01T00:00:002000HTLV type 1 Tax transduction in microglial cells and astrocytes by lentiviral vectors.true1ProfessorProfessortrue1Assistant ProfessorAssistant Professor